APA (7th ed.) Citation

HT, H., HC, H., CW, C., CC, C., T, H., HF, W., . . . Y, C. (2022). CXCR4-targeted nitric oxide nanoparticles deliver PD-L1 siRNA for immunotherapy against glioblastoma. Journal of controlled release : official journal of the Controlled Release Society, 352, 920. https://doi.org/10.1016/j.jconrel.2022.10.047

Chicago Style (17th ed.) Citation

HT, Hsieh, et al. "CXCR4-targeted Nitric Oxide Nanoparticles Deliver PD-L1 SiRNA for Immunotherapy Against Glioblastoma." Journal of Controlled Release : Official Journal of the Controlled Release Society 352 (2022): 920. https://doi.org/10.1016/j.jconrel.2022.10.047.

MLA (9th ed.) Citation

HT, Hsieh, et al. "CXCR4-targeted Nitric Oxide Nanoparticles Deliver PD-L1 SiRNA for Immunotherapy Against Glioblastoma." Journal of Controlled Release : Official Journal of the Controlled Release Society, vol. 352, 2022, p. 920, https://doi.org/10.1016/j.jconrel.2022.10.047.